Published

Synapticure Secures $25M To Scale Virtual Care for Neurodegenerative Diseases

Summary by MedCity News
Synapticure, a virtual care company for neurodegenerative diseases, has secured $25 million in Series A funding to scale its services and expand its partnerships with health systems, payers and providers, it announced Tuesday. Chicago-based Synapticure serves people and their families living with neurodegenerative diseases like Alzheimer’s, Parkinson’s and ALS. Its virtual platform provides access to neurologists, treatments, trials, care coordi…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)